Monopar Therapeutics — 8-K Filings
109 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Monopar Therapeutics (MNPR), sorted by most recent first. Each row links to the full filing on EdgarLookup. Monopar Therapeutics has filed 109 8-K documents with the SEC since 2015. To view all SEC filings by Monopar Therapeutics, see the full filings list.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001654954-23-003383 | Mar 23, 2023 | — |
| 8-K | FORM 8-K | 0001654954-23-002082 | Feb 27, 2023 | — |
| 8-K | FORM 8-K | 0001654954-23-001634 | Feb 14, 2023 | — |
| 8-K | FORM 8-K | 0001654954-23-000825 | Jan 26, 2023 | — |
| 8-K | FORM 8-K | 0001654954-23-000519 | Jan 18, 2023 | — |
| 8-K | FORM 8-K | 0001654954-22-016326 | Dec 12, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-015397 | Nov 16, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-014938 | Nov 10, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-013366 | Oct 5, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-011014 | Aug 11, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-009047 | Jun 30, 2022 | Jun 28, 2022 |
| 8-K | FORM 8-K | 0001654954-22-006509 | May 12, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-005218 | Apr 20, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-004477 | Apr 1, 2022 | Mar 28, 2022 |
| 8-K | FORM 8-K | 0001654954-22-003700 | Mar 24, 2022 | — |
| 8-K | FORM 8-K | 0001654954-22-001669 | Feb 15, 2022 | — |
| 8-K | FORM 8-K | 0001654954-21-012931 | Dec 8, 2021 | — |
| 8-K | CURRENT REPORT | 0001654954-21-012024 | Nov 12, 2021 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-011373 | Oct 27, 2021 | — |
| 8-K | CURRENT REPORT | 0001654954-21-010134 | Sep 16, 2021 | — |
| 8-K | CURRENT REPORT | 0001654954-21-009970 | Sep 13, 2021 | — |
| 8-K | CURRENT REPORT | 0001654954-21-008790 | Aug 12, 2021 | — |
| 8-K | FORM 8-K | 0001654954-21-008536 | Aug 5, 2021 | — |
| 8-K | FORM 8-K | 0001654954-21-008435 | Aug 3, 2021 | — |
| 8-K | CURRENT REPORT | 0001654954-21-007791 | Jul 12, 2021 | — |
| 8-K | CURRENT REPORT | 0001654954-21-007588 | Jul 2, 2021 | Jun 30, 2021 |
| 8-K | CURRENT REPORT | 0001654954-21-007211 | Jun 24, 2021 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-006545 | Jun 3, 2021 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-006486 | Jun 1, 2021 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-006463 | Jun 1, 2021 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-006283 | May 26, 2021 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-006178 | May 24, 2021 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-005622 | May 13, 2021 | Mar 31, 2021 |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-003450 | Mar 30, 2021 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-003244 | Mar 25, 2021 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-001659 | Feb 16, 2021 | Feb 1, 2021 |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-001477 | Feb 11, 2021 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-21-001326 | Feb 9, 2021 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-013816 | Dec 22, 2020 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-013341 | Dec 10, 2020 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-013273 | Dec 8, 2020 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-012193 | Nov 12, 2020 | Sep 30, 2020 |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-011972 | Nov 9, 2020 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-009918 | Sep 9, 2020 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-009323 | Aug 19, 2020 | Aug 17, 2020 |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-008903 | Aug 12, 2020 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-008682 | Aug 10, 2020 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-008589 | Aug 6, 2020 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-007116 | Jun 30, 2020 | — |
| 8-K | PRIMARY DOCUMENT | 0001654954-20-006669 | Jun 16, 2020 | — |